GlobeNewswire by notified

Kinnevik: Extraordinary General Meeting 2021

Share

Kinnevik AB (publ) ("Kinnevik") today held an Extraordinary General Meeting(the "EGM"). Due to the continuing coronavirus pandemic, the EGM was held only through postal voting in accordance with temporary legislation. The EGM resolved in accordance with the Board's proposal regarding a long-term share incentive plan for Kinnevik employees.

The EGM resolved to adopt a long-term share incentive plan for Kinnevik employees, including resolutions to amend Kinnevik's Articles of Association with the introduction of two new incentive share classes of Class C 2021 and Class D 2021 that in 2027 are reclassifiable into class B shares, to transfer up to 368,500 incentive shares of Class C 2021 and 368,500 incentive shares of Class D 2021 free-of-charge to Kinnevik employees that decides to participate in the plan, as well as to transfer up to 58,275 incentive shares of Class C 2021 and 58,275 incentive shares of Class D 2021, at market value, to the Chief Executive Officer and senior members of Kinnevik's investment team that is provided the opportunity to acquire additional incentive shares using their own capital.

The EGM further resolved to secure each of the undertakings to deliver incentive shares to the participants in the 2021 long-term share incentive plan by authorising the Board to resolve on a directed issue of incentive shares to a bank, and immediately thereafter repurchase such shares.

The complete documentation related to the proposals adopted by the EGM can be found on Kinnevik's website at www.kinnevik.com under the heading "General Meetings" (which can be found under the section "Governance").

For further information, visit www.kinnevik.com or contact:

Torun Litzén, Director Investor Relations
Phone +46 (0)70 762 00 50
Email press@kinnevik.com

Kinnevik’s ambition is to be Europe’s leading listed growth investor, and we back the best digital companies for a reimagined everyday and to deliver significant returns. We understand complex and fast-changing consumer behaviours, and have a strong and expanding portfolio in healthtech, consumer services, foodtech and fintech. As a long-term investor, we strongly believe that investing in sustainable business models and diverse teams will bring the greatest returns for shareholders. We back our companies at every stage of their journey and invest in Europe, with a focus on the Nordics, and in the US. Kinnevik was founded in 1936 by the Stenbeck, Klingspor and von Horn families. Kinnevik’s shares are listed on Nasdaq Stockholm’s list for large cap companies under the ticker codes KINV A and KINV B.

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

EBC Financial Group (Cayman) Limited Granted Full Regulatory Licence from the Cayman Islands Monetary Authority (CIMA)28.3.2024 11:53:45 CET | Press release

EBC Financial Group strengthens its global presence with full CIMA licence, underscoring the group’s commitment to stringent global regulatory standards HONG KONG, March 28, 2024 (GLOBE NEWSWIRE) -- EBC Financial Group (EBC Group or EBC) is pleased to announce that its Cayman Islands subsidiary, EBC Financial Group (Cayman) Limited, has been awarded a full Cayman Islands Monetary Authority (CIMA) licence. This significant achievement marks a major advancement in EBC's global regulatory portfolio, following its existing accreditations from the UK's Financial Conduct Authority (FCA) and the Australian Securities and Investments Commission (ASIC). Within CIMA's strict regulatory framework, EBC will offer more comprehensive financial services, including trusts, securities, futures, and funds, specifically catering to retail, professional, high-net-worth individuals and institutional investors. The Cayman Islands, recognized as a premier offshore financial centre, gathers 90% of the world's

Changes in financial calender28.3.2024 11:30:00 CET | Press release

According to the AS Pro Kapital Grupp 2024 financial calendar, the Company should publish its audited financial results for 2023 on 30 April 2024. AS Pro Kapital Grupp announces that it will publish its audited financial results for 2023 earlier than foreseen in the Company's financial calendar and the audited results for 2023 will be published between 10-12 April 2024. Ann-Kristin Kuusik CFO Phone: +372 614 4920 e-mail: prokapital@prokapital.ee

Meriaura Group Plc’s annual report for 2023 published28.3.2024 11:30:00 CET | Press release

Meriaura Group Plc Company Announcement 28 April 2024 at 11.30 a.m. (CET) Meriaura Group Plc’s annual report for 2023 published Meriaura Group Plc’s annual report including the annual accounts, the report of the Board of Directors and the auditor’s report for the year 2023 has been published. The annual report is available at the company’s website https://meriauragroup.com/investors/reports-and-presentations/financial-reports/ and it’s also attached to this announcement. The annual report is available in pdf format in Finnish and in English. MERIAURA GROUP PLC Further information: CEO Kirsi Suopelto Tel: +358 505 602 349 Email: kirsi.suopelto@meriaura.com Meriaura Group in brief Meriaura Group has two business areas: Marine Logistics and Renewable Energy. Marine Logistics business is carried out by Meriaura Ltd, which is a major provider of transport for bulk cargo and demanding project deliveries in Northern Europe, especially in the Baltic Sea and North Sea regions. The company provi

Calibre Enters Pre-Commissioning and Commissioning Contract with Reliable Controls Corporation and Executes A Gold Prepayment28.3.2024 11:00:16 CET | Press release

VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Calibre Mining Corp. (TSX: CXB; OTCQX: CXBMF) (“Calibre” or the “Company”) is pleased to announce the Company has entered into a key pre-commissioning and commissioning contract with Reliable Controls Corporation of Salt Lake City (“RCC”) for the Company’s Valentine Gold Mine (“VGM”) in Newfoundland and Labrador. The Company has also executed a US$60 million short term, gold prepayment agreement with Asahi Refining USA Inc. (“Asahi”), pursuant to which Asahi has agreed to purchase a total of 27,600 ounces of gold from the Company, comprising less than 10% of the Company’s expected 2024 gold production. Darren Hall, President and Chief Executive Officer of Calibre, stated: “With construction at Valentine 61% complete I remain confident in our ability to deliver first gold during H1, 2025. To further derisk delivery, I am pleased to announce that we have secured RCC, a team of highly experienced commissioning experts to lead

Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors28.3.2024 11:00:00 CET | Press release

VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced the appointment of Dr. Neil Gallagher to its board of directors effective April 2, 2024. “Dr. Gallagher is the sixth director to join our board of directors in the past twelve months as we continue to refresh and strengthen the Board governance and oversight required for the next stage of the Company’s development and growth,” said Kenneth Galbraith, Chair and Chief Executive Officer of Zymeworks. “His experience and leadership in leading multiple development programs through to global regulatory approval will support our efforts to rapidly advance our ‘5 by 5’ programs into clinical studies and our continued pipeline expansion of novel antibody-drug conjugates and multispecific antibodies in the years a

HiddenA line styled icon from Orion Icon Library.Eye